Inicio・Lista de Acciones・Compugen Ltd

Compugen Ltd

Cerrado

2.11 -1.86

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

2.02

Máximo

2.15

Métricas clave
By Trading Economics
Ingresos	663K -7M
Ventas	426K 2.6M
P/B Media del Sector	6.079 47.946
BPA	-0.07
Margen de beneficios	-269.254
Empleados	75
EBITDA	665K -7M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+112.26% upside

Dividendos
By Acuity
Próximas Ganancias	9 nov 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-6.3M 219M
Apertura anterior	3.97
Cierre anterior	2.11

Compugen Ltd Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

8 oct 2026, 23:56 UTC

Southwest Gas Holdings Inc's shares were roughly flat in after-market trading, showing limited movement since Thursday's close within a narrow range.

8 oct 2026, 23:56 UTC

Yum Brands Inc. is experiencing a decline in after-market trading, retracing to near the low end of its range following four consecutive higher daily closes.

8 oct 2026, 23:56 UTC

Correlated Moves

TE Connectivity PLC is trading modestly higher in after-market hours, supported by positive market sentiment following improved Medicare Advantage Star Ratings for Humana.

8 oct 2026, 23:56 UTC

Dropbox Inc shares are trading slightly higher in after-market hours, rebounding from an initial dip since Thursday's close.

8 oct 2026, 23:56 UTC

Fluor Corp's shares are trading lower in after-market hours, declining slightly since Thursday's close and remaining below its 20-day moving average.

8 oct 2026, 23:56 UTC

T Rowe Price Group Inc's shares traded roughly flat in after-market hours, reflecting stable conditions with slight fluctuations around Thursday's close.

8 oct 2026, 23:56 UTC

Correlated Moves

Southside Bancshares Inc's shares were little changed in after-market trading, remaining below their 20-day moving average amid broader subdued performance.

8 oct 2026, 23:56 UTC

Correlated Moves

Peoples Bancorp Inc is trading slightly higher in after-market hours, moving in sympathy with Nicolet Bankshares, Inc, which has also gained ground.

8 oct 2026, 23:56 UTC

Correlated Moves

United Bankshares Inc is little changed in after-market trading, moving in sympathy with Nicolet Bankshares, which has seen a slight increase since the previous close.

8 oct 2026, 23:56 UTC

Correlated Moves

Hancock Whitney Corp is slightly higher in after-market hours following Nicolet Bankshares, Inc.'s earnings release, despite its price remaining little changed overall.

8 oct 2026, 23:56 UTC

Stanley Black & Decker Inc shares are trading lower in after-market hours, retracing from earlier gains and nearing the lower end of their one-month trading range.

8 oct 2026, 23:56 UTC

Correlated Moves

Independent Bank Corp is little changed in after-market trading, moving in sympathy with Nicolet Bankshares, which has seen unusual activity.

8 oct 2026, 23:56 UTC

Wyndham Hotels & Resorts Inc saw a modest rise in after-market trading, remaining above its 20-day moving average and near the upper end of its one-month range.

8 oct 2026, 23:56 UTC

Novanta Inc shares are trading slightly higher in after-market hours, maintaining a flat position since Thursday's close, despite recent lower finishes.

8 oct 2026, 23:56 UTC

Correlated Moves

NBT Bancorp Inc is trading higher in after-market hours, moving in sympathy with Nicolet Bankshares, which has also gained ground.

8 oct 2026, 23:55 UTC

New Jersey Resources Corp is trading higher in after-market hours, recovering from an early decline, though still below its 20-day moving average.

8 oct 2026, 23:55 UTC

Match Group Inc shares are trading modestly lower in after-market hours, continuing a trend seen in earlier sessions despite recent gains in the previous three trading days.

8 oct 2026, 23:55 UTC

Monster Beverage Corp shares are trading modestly higher in after-market hours, maintaining an upward trend since Thursday's close and staying above its 20-day moving average.

8 oct 2026, 23:55 UTC

Coastal Financial Corp is trading higher in after-market hours, recovering from earlier lows.

8 oct 2026, 23:55 UTC

Geo Group Inc shares have drifted lower during after-market trading, retracing from an early peak and settling in the middle of their one-month trading range.

8 oct 2026, 23:55 UTC

Wix.Com Ltd's shares traded roughly flat during after-market hours, showing a slight upward drift from earlier negative territory, remaining below its 20-day moving average.

8 oct 2026, 23:55 UTC

Motorola Solutions Inc. is trading higher in after-market hours, though it remains below its 20-day moving average and near the lower end of its one-month range.

8 oct 2026, 23:55 UTC

Enpro Inc's shares are trading higher in after-market hours, gaining slightly since Thursday's close amid a broader market trend of four consecutive lower sessions.

8 oct 2026, 23:55 UTC

Azenta Inc shares are trading slightly higher in after-market hours, maintaining a position above the 20-day moving average following recent declines.

8 oct 2026, 23:55 UTC

Crocs Inc shares are modestly higher in after-market hours, settling around recent levels after a sharp rise earlier in the session.

8 oct 2026, 23:55 UTC

Advance Auto Parts Inc shares traded roughly flat during after-market hours, maintaining a narrow range since Thursday's close and positioned above its 20-day moving average.

8 oct 2026, 23:55 UTC

Constellation Energy Corp is trading modestly higher in after-market hours, remaining above its 20-day moving average and near the upper end of its one-month range.

8 oct 2026, 23:55 UTC

NNN REIT Inc has advanced modestly in after-market trading, recovering from an initial dip to close at its highest level of the session.

8 oct 2026, 23:55 UTC

Pinnacle Financial Partners Inc is seeing a slight increase in after-market trading, gaining ground since Thursday's close while remaining near the lower end of its one-month range.

8 oct 2026, 23:55 UTC

Lindsay Corp's shares are modestly higher in after-market trading, recovering from earlier lows while approaching the session's highest point.

Comparación entre iguales

Cambio de precio

Compugen Ltd previsión

Precio Objetivo

By TipRanks

112.26% repunte

Estimación a 12 Meses

Media 4.5 USD 112.26%

Máximo 6 USD

Mínimo 4 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Compugen Ltd Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

Comprar

Mantener

Vender

De acuerdo con 4 analistas que ofrecen calificaciones bursátiles a para Compugen Ltd Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.